Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Distinct Clinical and Biological Implications of Various DNTMT3A Mutations in Myeloid Neoplasms

Suresh Kumar Balasubramanian, MD, Mai Ali, Taha Bat, MD, Bhumika Patel, MD, Bartlomiej P Przychodzen, MSc, Cassandra M. Hirsch, BSc, Aziz Nazha, MD, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Jaroslaw P Maciejewski, MD PhD FACP

Blood (2016) 128 (22): 2872.

https://doi.org/10.1182/blood.V128.22.2872.2872

Published: 2016

Journal Articles

Subcutaneous Low Dose Alemtuzumab: Role As a Salvage Therapy in Immune -Mediated Marrow Failure Conditions

Swapna Thota, MD, Srinivasa Reddy Sanikommu, MD, Bhumika Patel, MD, Meena Sadaps, Cassandra M. Hirsch, BSc, Michael J. Clemente, M.S., Serena Marotta, MD, Antonio M Risitano, MD PhD, Mikkael A. Sekeres, MD MS, Jaroslaw P Maciejewski, MD PhD FACP

Blood (2016) 128 (22): 1505.

https://doi.org/10.1182/blood.V128.22.1505.1505

Published: 2016

Journal Articles

Prognostic Parameters in Adults with Acute Lymphoblastic Leukemia at Second Complete Response

Caner Saygin, MD, Nikolaos Papadantonakis, MD PhD, Ryan D Cassaday, MD, Michaela Liedtke, MD, Katrina Fischer, MD, Tamara J. Dunn, MD, Bhumika Patel, MD, Sean Hobson, Cassie Zimmerman, Jaime Lynn Fensterl, MS, MBA, Ronald M. Sobecks, MD, Matt Kalaycio, MD FACP, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MD, PhD, M.P.H., Aaron T. Gerds, MD MS, Betty K. Hamilton, MD, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD

Blood (2016) 128 (22): 1603.

https://doi.org/10.1182/blood.V128.22.1603.1603

Published: 2016

Journal Articles

Clonal Dynamics of Refractory Aplastic Anemia in Patients Treated with Eltrombopag

Bhumika Patel, MD, Bartlomiej P Przychodzen, MSc, Michael J. Clemente, M.S., Cassandra M. Hirsch, BSc, Caner Saygin, MD, Marissa Versalle, MD, Swapna Thota, MD, Aziz Nazha, MD, Roy Souaid, MD, Valeria Visconte, PhD, Taha Bat, MD, Suresh Kumar Balasubramanian, MD, Tomas Radivoyevitch, PhD, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Jaroslaw P Maciejewski, MD PhD FACP

Blood (2016) 128 (22): 3892.

https://doi.org/10.1182/blood.V128.22.3892.3892

Published: 2016

Journal Articles

BCOR and BCORL1 mutations in Myelodysplastic Syndromes (MDS): Clonal Architecture and Impact on Outcomes

Nour Abuhadra, MD, Karam Al-Issa, MD, Aaron T. Gerds, MD MS, Sudipto Mukherjee, MD, PhD, M.P.H., Bhumika Patel, MD, Michael J. Clemente, M.S., Vera Adema, PhD, Cassandra M. Hirsch, BSc, Anjali S. Advani, MD, Mai Aly, Przychodzen P Bartlomiej, Hetty E. Carraway, MD, Jaroslaw P Maciejewski, MD PhD FACP, Mikkael A. Sekeres, MD MS, Aziz Nazha, MD

Blood (2016) 128 (22): 4293.

https://doi.org/10.1182/blood.V128.22.4293.4293

Published: 2016

Journal Articles

TP53 Mutations and Outcome in Patients with Myelodysplastic Syndromes (MDS)

Karam Al-Issa, MD, Mikkael A. Sekeres, MD MS, Alek d Nielsen, B.S., Babal Jha, PhD, Bartlomiej P Przychodzen, MSc, Mai Aly, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD, Bhumika Patel, MD, Michael J. Clemente, M.S., Sudipto Mukherjee, MD, PhD, M.P.H., Aaron T. Gerds, MD MS, Jaroslaw P Maciejewski, MD PhD FACP, Aziz Nazha, MD

Blood (2016) 128 (22): 4336.

https://doi.org/10.1182/blood.V128.22.4336.4336

Published: 2016

Journal Articles

Genetic and Epigenetic Defects in the Autophagy Machinery in Myelodysplastic Syndromes

Valeria Visconte, PhD, Bartlomiej P Przychodzen, MSc, Steffan T. Nawrocki, PhD, Swapna Thota, MD, Kevin R. Kelly, MD PhD, Bhumika Patel, MD, Cassandra M. Hirsch, BSc, Hetty E. Carraway, MD MBA, Yvonne Parker, Daniel Lindner, Mikkael A. Sekeres, MD MS, Heesun J Rogers, MD PhD, Jaroslaw P. Maciejewski, MD, PhD, FACP, Jennifer S. Carew, PhD

Blood (2016) 128 (22): 4301.

https://doi.org/10.1182/blood.V128.22.4301.4301

Published: 2016

Journal Articles

Impact of Erythropoietic Stimulating Agents on Mutational Composition in Patients with Low-Risk Myelodysplastic Syndromes

Bhumika Patel, MD, Caner Saygin, MD, Bartlomiej P Przychodzen, MSc, Teodora Kuzmanovic, BSc, Cassandra M. Hirsch, BSc, Michael J. Clemente, M.S., Swapna Thota, MD, Aziz Nazha, MD, Sekeres A Mikkael, MD, Jaroslaw P Maciejewski, MD PhD FACP, Hetty E. Carraway, MD MBA

Blood (2016) 128 (22): 2002.

https://doi.org/10.1182/blood.V128.22.2002.2002

Published: 2016

Journal Articles

IPI, Comorbidity Index, Hospitalization for Treatment-Related Adverse Events Are Predictors for Outcome in Elderly Diffuse Large B Cell Lymphoma Patients

Caner Saygin, MD, Xuefei Jia, MS, Brian T. Hill, MD PhD, Robert M. Dean, MD, Bhumika Patel, MD, Brad Pohlman, MD, Mitchell R. Smith, Deepa Jagadeesh, MD MPH

Blood (2016) 128 (22): 1860.

https://doi.org/10.1182/blood.V128.22.1860.1860

Published: 2016

Journal Articles

Deletion of PTPN1 Promotes the Development of Myelofibrosis

Fatoumata Jobe, PhD, Bhumika Patel, MD, Hideki Makishima, MD PhD, Bartlomiej P Przychodzen, MSc, Robert E Hutchison, MD, Kendra K Bence, PhD, Jaroslaw P Maciejewski, MD PhD FACP, Golam Mohi, PhD

Blood (2016) 128 (22): 795.

https://doi.org/10.1182/blood.V128.22.795.795

Published: 2016

Journal Articles

Incorporation of Molecular Data into the Current Prognostic Models in Treated Patients with Myelodysplastic Syndromes: Which Model Is the Best

Karam Al-Issa, MD, Ahmad Zarzour, MD, Tomas Radivoyevitch, PhD, Matt Kalaycio, MD, Betty K. Hamilton, MD, Aaron T. Gerds, MD MS, Sudipto Mukherjee, MD, PhD, M.P.H., Vera Adema, PhD, Michael J. Clemente, M.S., Bhumika Patel, MD, Cassandra M. Hirsch, BSc, Anjali S. Advani, MD, Bartlomiej P Przychodzen, MSc, Hetty E. Carraway, MD MBA, Jaroslaw P Maciejewski, MD PhD FACP, Mikkael A. Sekeres, MD MS, Aziz Nazha, MD

Blood (2016) 128 (22): 50.

https://doi.org/10.1182/blood.V128.22.50.50

Published: 2016

Journal Articles

Molecular and Immunophenotypic Characteristics of Adult Acute Leukemias of Ambiguous Lineage

Bhumika Patel, MD, Caner Saygin, MD, Bartlomiej P Przychodzen, MSc, Cassandra M. Hirsch, BSc, Michael J. Clemente, M.S., Betty K. Hamilton, MD, Anjali S. Advani, MD, Aziz Nazha, MD, Sarah Lynn Ondrejka, DO, Matt Kalaycio, MD, Mikkael A. Sekeres, MD MS, Hetty E. Carraway, MD MBA, Jaroslaw P Maciejewski, MD PhD FACP

Blood (2016) 128 (22): 1659.

https://doi.org/10.1182/blood.V128.22.1659.1659

Published: 2016

NARROW

Distinct Clinical and Biological Implications of Various DNTMT3A Mutations in Myeloid Neoplasms

Subcutaneous Low Dose Alemtuzumab: Role As a Salvage Therapy in Immune -Mediated Marrow Failure Conditions

Prognostic Parameters in Adults with Acute Lymphoblastic Leukemia at Second Complete Response

Clonal Dynamics of Refractory Aplastic Anemia in Patients Treated with Eltrombopag

BCOR and BCORL1 mutations in Myelodysplastic Syndromes (MDS): Clonal Architecture and Impact on Outcomes

TP53 Mutations and Outcome in Patients with Myelodysplastic Syndromes (MDS)

Genetic and Epigenetic Defects in the Autophagy Machinery in Myelodysplastic Syndromes

Impact of Erythropoietic Stimulating Agents on Mutational Composition in Patients with Low-Risk Myelodysplastic Syndromes

IPI, Comorbidity Index, Hospitalization for Treatment-Related Adverse Events Are Predictors for Outcome in Elderly Diffuse Large B Cell Lymphoma Patients

Deletion of PTPN1 Promotes the Development of Myelofibrosis

Incorporation of Molecular Data into the Current Prognostic Models in Treated Patients with Myelodysplastic Syndromes: Which Model Is the Best

Molecular and Immunophenotypic Characteristics of Adult Acute Leukemias of Ambiguous Lineage

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only